PRECISION BIOSCIENCES INC — Director's Dealing 2019

Oct 8, 2019

SEC Form 3 — Initial Statement of Beneficial Ownership

Issuer: PRECISION BIOSCIENCES INC (DTIL)
CIK: 0001357874
Period of Report: 2019-09-30

Reporting Person: Heery Christopher (Chief Medical Officer)

Holdings (Derivative)

Security	Exercise Price	Expiration	Underlying	Shares	Ownership
Employee Stock Option (Right to Buy)	$13.39	2029-07-03	Common Stock (200000)		Direct

Footnotes

F1: The option vests as to 25% of the underlying shares on July 4, 2020 and, as to the remaining underlying shares, vests in equal installments of 6.25% at the end of each successive three-month period over the 36 months following such date.